C

Cellectis SA
D

CLLS

1.45000
USD
0.04
(2.84%)
مغلق
حجم التداول
212
الربح لكل سهم
-1
العائد الربحي
-
P/E
-2
حجم السوق
146,042,512
أصول ذات صلة المقالات
المزيد

العنوان: Cellectis SA

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.